Jane Street Group, LLC Precision Biosciences Inc Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$7.4 - $11.66 $91,020 - $143,418	-12,300 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$9.18 - $14.15 $14,688 - $22,640	-1,600 Reduced 11.51%	12,300 $142,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $112,173 - $174,028	13,900 New	13,900 $174,000
Q1 2021 May 18, 2021	SELL	$8.57 - $15.79 $134,549 - $247,903	-15,700 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$5.98 - $12.47 $93,886 - $195,779	15,700 New	15,700 $131,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $802M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.